BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16332594)

  • 1. The potential of proton beam therapy in paediatric cancer.
    Björk-Eriksson T; Glimelius B
    Acta Oncol; 2005; 44(8):871-5. PubMed ID: 16332594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of proton beam radiation therapy in breast cancer.
    Björk-Eriksson T; Glimelius B
    Acta Oncol; 2005; 44(8):884-9. PubMed ID: 16332597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of proton beam radiation therapy in head and neck cancer.
    Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
    Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Johansson B; Ridderheim M; Glimelius B
    Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
    Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):881-3. PubMed ID: 16332596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of proton beam radiation therapy in gastrointestinal cancer.
    Ask A; Johansson B; Glimelius B
    Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of proton beam radiation for palliation and reirradiation.
    Björk-Eriksson T; Ask A; Glimelius B
    Acta Oncol; 2005; 44(8):918-20. PubMed ID: 16332602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.
    Björk-Eriksson T; Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):913-7. PubMed ID: 16332601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of patients potentially eligible for proton therapy.
    Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
    Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of proton beam radiation therapy in intracranial and ocular tumours.
    Blomquist E; Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):862-70. PubMed ID: 16332593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
    Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
    Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Cancer; 2005 Feb; 103(4):793-801. PubMed ID: 15637691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary neutrons in clinical proton radiotherapy: a charged issue.
    Brenner DJ; Hall EJ
    Radiother Oncol; 2008 Feb; 86(2):165-70. PubMed ID: 18192046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancers in children treated with modern radiotherapy techniques.
    Schneider U; Lomax A; Timmermann B
    Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.
    Newhauser W; Fontenot J; Zheng Y; Polf J; Titt U; Koch N; Zhang X; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4569-84. PubMed ID: 17634651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.